CLINICAL AND DIAGNOSTIC VALUE OF STUDIES OF ENDOTHELIAL DYSFUNCTION MARKERS IN PATIENTS WITH ISCHEMIC HEART DISEASE

QR Code

CLINICAL AND DIAGNOSTIC VALUE OF STUDIES OF ENDOTHELIAL DYSFUNCTION MARKERS IN PATIENTS WITH ISCHEMIC HEART DISEASE

In this paper we have carried out the diagnosis of the damage of the vascular endothelium in patients with ischemic heart disease (IHD) based on the study of gene of endothelial nitric oxide synthase polymorphism, the condition of vasoregulating function of endothelium, endothelin-1 and the level of...

Full description

Saved in:

Bibliographic Details
Main Authors:	A. Kh. Akhmineeva, O. S. Polunina, L. P. Voronina, I. V. Sevostyanova
Format:	Article
Language:	Russian
Published:	Ministry of Healthcare of the Russian Federation. “Kuban State Medical University” 2014-02-01
Series:	Кубанский научный медицинский вестник
Subjects:	ишемическая болезнь сердца полиморфизм гена эндотелиальной синтазы оксида азота эндотелин-1 натрийуретический пептид типа с эндотелиальная дисфункция ischemic heart disease gene of endothelial nitric oxide synthase polymorphism endothelin-1 type c of natriuretic peptide endothelial dysfunction
Online Access:	https://ksma.elpub.ru/jour/article/view/7
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

BIOCHEMICAL AND GENETIC ASPECTS OF THE CHRONIC OBSTRUCTIVE PULMONARY DISEASE AND ARTERIAL HYPERTENSION COMBINATION
by: O. S. Polunina, et al.
Published: (2014-02-01)

RETRACTED: Arginase II - a new target in the development of endothelium protectors
by: V. I. Yakushev, et al.
Published: (2018-02-01)

THE RELATIONSHIP BETWEEN THE LEVEL OF SUPEROXIDDISMUTASE AND THE COEFFICIENT OF ENDOTHELIAL FUNCTION AT RESPIRATORY-CARDIAC COMORBIDITY
by: O. S. Polunina, et al.
Published: (2014-02-01)

Pathogenetic features of endothelial dysfunction at respiratory-cardiac comorbidity
by: A. Kh. Akhmineeva, et al.
Published: (2014-08-01)

Vascular endothelial dysfunction and comorbid conditions in bronchial asthma
by: A. Kh. Akhmineeva, et al.
Published: (2014-04-01)

Lead acetate deteriorates the improvement effect of L-arginine and tetrahydrobiopterin on endothelin-1 receptors activity in rat aorta
by: Zhikal Omar Khudhur, et al.
Published: (2023-10-01)

ENDOTHELIOPROTECTIVE AND CARDIOPROTECTIVE ACTIVITY OF SELECTIVE ARGINASE II INHIBITOR
by: V. I. Yakushev, et al.
Published: (2015-06-01)

NEW OPPORTUNITIES PATHOGENETIC THERAPY OF PULMONARY ARTERIAL HYPERTENSION
by: T. V. Martynuk, et al.
Published: (2013-03-01)

FEATURES OF THE SYNTHESIS OF NITRIC OXIDE IN PATIENTS WITH BRONCHIONAL ASTHMA AND CHRONIC OBSTRUCTIVE PULMONARY DISEASE
by: Z. O. Dzuskaeva, et al.
Published: (2015-06-01)

CEREBRAL CIRCULATION AND COGNITIVE STATUS OF CORONARY HEART DISEASE PATIENTS AFTER BYPASS SURGERY
by: М. М. Petrova, et al.
Published: (2017-10-01)

Dynamics of laboratory markers of endothelial dysfunction in patients with psoriatic arthritis under the influence of the interleukin-17A inhibitor netakimab
by: A. V. Petrov, et al.
Published: (2024-12-01)

PHYSICAL METHODS OF REHABILITATION OF PATIENTS WITH CORONARY HEART DISEASE. PROS AND CONS. A LITERARY DIGRESSION INTO THE PROBLEM
by: Алексей Алексеевич Марцияш, et al.
Published: (2022-11-01)

The level of the cardiac peptide NT-proBNP and indices of the scale of assessment of clinical status in chronic heart failure patients with ischemic cardiomyopathy
by: E. I. Myasoedova, et al.
Published: (2016-06-01)

Markers of endothelial dysfunction in pregnant women with the A2 gene polymorphism of platelet glycoprotein receptors IIb/IIIa
by: A. Y. Muratova, et al.
Published: (2016-02-01)

MODERN VIEWS ABOUT THE PATHOPHYSIOLOGY OF ATHEROSCLEROSIS. PART 1. THE ROLE OF IMPAIRED LIPID METABOLISM AND ENDOTHELIAL DYSFUNCTION (LITERATURE REVIEW)
by: Алексей Михайлович Чаулин, et al.
Published: (2020-06-01)

THE ROLE OF FRACTALKINE AS A MARKER OF THE INFLAMMATORY ACTIVITY AT COMBINED RESPIRATORY CARDIAC PATHOLOGY
by: A. Kh. Akhmineeva, et al.
Published: (2014-02-01)

Combined use of statins and inhibitors of arginase l-norvaline for correcting endotoksin-inducing endotelial dysfunction
by: T. A. Denisyuk, et al.
Published: (2016-02-01)

Correction of endotoxin-induced endothelial dysfunction by recombinant erythropoetin and inhibitors of HMG-Co-A-reductase
by: T. A. Denisyuk, et al.
Published: (2015-12-01)

МЕТОДЫ СТАНДАРТИЗАЦИИ В ОПРЕДЕЛЕНИИ МЕСТА ВНЕЗАПНОЙ КОРОНАРНОЙ СМЕРТИ СРЕДИ ПРОЧИХ ФОРМ ИШЕМИЧЕСКОЙ БОЛЕЗНИ СЕРДЦА
Published: (2006-12-01)

Polyvascular disease in the real practice of a cardiologist: what we know and where efforts should be concentrated
by: E. V. Shlyakhto
Published: (2024-05-01)

The role of arginine and endothelial nitric oxide synthase in the pathogenesis of Covid-19 complicated by metabolic syndrome
by: L. A. Kuznetsova, et al.
Published: (2022-12-01)

Morphofunctional changes in ventral and dorsal hippocampus in adult rats after chronic mild stress: a preclinical experimental study
by: I. N. Tyurenkov, et al.
Published: (2024-04-01)

Clinical role of endothelial dysfunction and hemostasis gene allelic variants in hepatitis C virus-associated cryoglobulinemia
by: M. V. Sokolova, et al.
Published: (2018-08-01)

Role of nitric oxide and endothelial NO synthase in carcinogenesis
by: V. P. Deryagina, et al.
Published: (2021-07-01)

Own and parental predictors of tobacco smoking in children with early coronary heart disease
by: M. V. Konnov, et al.
Published: (2020-11-01)

ПРОПАФЕНОН – ТЕРАПЕВТИЧЕСКИЙ ЭФФЕКТ И ВЛИЯНИЕ НА КАЧЕСТВО ЖИЗНИ У БОЛЬНЫХ С ЭКСТРАСИСТОЛИЕЙ
Published: (2006-12-01)

INFLUENCE OF EDUCATIONAL LEVEL ON THE NEUROPHYSIOLOGICAL STATUS OF PATIENTS WITH CORONARY ARTERY DISEASE
by: Рамиль Мансурович Акбиров, et al.
Published: (2018-12-01)

PATHOMORPHOLOGICAL CHANGES IN ORGANS WITH A COMBINATION OF NEW CARONAVIRAL INFECTION (COVID-19) AND PNEUMOCONIOSIS IN WORKERS OF THE COAL INDUSTRY OF KUZBASS
by: Олег Иванович Бондарев, et al.
Published: (2020-12-01)

КОРРЕКЦИЯ ЭНДОТЕЛИАЛЬНОЙ ДИСФУНКЦИИ У БОЛЬНЫХ ХРОНИЧЕСКИМ ЛЕГОЧНЫМ СЕРДЦЕМ ИНГИБИТОРАМИ АНГИОТЕНЗИНПРЕВРАЩАЮЩЕГО ФЕРМЕНТА
Published: (2005-12-01)

PROGNOSTIC SIGNIFICANCE OF THE VNTR POLYMORPHISM INTRON 4 OF THE GENE OF NITRIC OXIDE ENDOTHELIAL SYNTHASE IN CHRONIC HEART FAILURE PATIENTS
by: E. A. Polunina, et al.
Published: (2018-02-01)

CHANGES IN ENDOTHELIAL NO-SYNTHASE IN PREGNANT WOMEN WITH CHRONIC ARTERIAL HYPERTENSION AND SMOKING
by: Николай Андреевич Бичан, et al.
Published: (2021-08-01)

THE INVOLVEMENT OF ENDOTHELIAL DYSFUNCTION MARKERS IN THE PATHOGENESIS OF CHRONIC GLOMERULONEPHRITIS
by: T.V. Margieva, et al.
Published: (2006-03-01)

Changes in serum NO, ET-1, and VEGF after cannulated screw fixation in patients with femoral neck fractures and their relationship with femoral head necrosis
by: Ziqiang Li, et al.
Published: (2025-07-01)

Clinical and endoscopical and morphofunctional scores in evaluation of development of gastroesophageal reflux disease in various age groups
by: M. A. Osadchuk, et al.
Published: (2012-09-01)

ПОЛИМОРФИЗМ ГЕНА ЭНДОТЕЛИАЛЬНОЙ СИНТАЗЫ ОКСИДА АЗОТА И САХАРНЫЙ ДИАБЕТ 2 ТИПА (литературный обзор)
by: Ю. А. Сорокина, et al.
Published: (2014-12-01)

ACTIVITY MODULATION OF VARIOUS NITRIC OXIDE SYNTASES AS AN APPROACH TO ENDOTHELIAL DYSFUNCTION THERAPY
by: D. V. Kurkin, et al.
Published: (2022-05-01)

Dyslipidemia and endothelial function in women with metabolic syndrome associated with autoimmune thyroiditis
by: N. S. Kanavets, et al.
Published: (2014-09-01)

Shear Stress-Dependent Modulation of Endothelin B Receptor: The Role of Endothelial Glycocalyx Heparan Sulfate
by: Camden Holm, et al.
Published: (2025-07-01)

ENDOTHELIAL DYSFUNCTION AS CORNERSTONE OF CARDIOVASCULAR EVENTS: MOLECULAR AND PHARMACEUTIC ASPECTS
by: V. V. Kireeva, et al.
Published: (2014-10-01)

CLINICAL CASE OF SUCCESSFUL 10-YEAR AMBRIZENTAN TREATMENT OF THE PATIENT WITH IDIOPATHIC PULMONARY ARTERIAL HYPERTENSION
by: T. V. Martynyuk, et al.
Published: (2015-12-01)